Jason A Zell

Title: Jason A Zell: Innovator in Cancer Diagnosis and Treatment

Introduction

Jason A Zell is a prominent inventor based in Dana Point, California. He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of colorectal cancer. With a total of 3 patents to his name, his work focuses on innovative methods that enhance patient care and treatment options.

Latest Patents

One of Jason A Zell's latest patents is centered around carcinoma diagnosis and treatment based on the ODC1 genotype. This invention provides methods and kits for predicting colorectal cancer patient survival, as well as the survival of patients with other invasive cancers linked to high levels of ODC activity and increased cellular polyamine contents. The patent also outlines how to select appropriate treatment options based on the allelic nucleotide sequence or SNP at position +316 of the ODC1 promoter gene. This groundbreaking work aims to guide treatment selection through the determination of the ODC1 promoter +316 position genotype.

Career Highlights

Throughout his career, Jason A Zell has worked with esteemed institutions such as the University of Arizona and the University of California. His research has significantly impacted the understanding and treatment of cancer, showcasing his dedication to improving patient outcomes.

Collaborations

Jason has collaborated with notable individuals in the field, including Eugene W Gerner and Christine E McLaren. These partnerships have further enriched his research and contributed to the advancement of cancer treatment methodologies.

Conclusion

In summary, Jason A Zell is a dedicated inventor whose work in cancer diagnosis and treatment has the potential to transform patient care. His innovative approaches and collaborations highlight his commitment to advancing medical science and improving the lives of those affected by cancer.